Brokerages maintain cautious stance on Dr. Lal PathLabs post Q2 recovery
The diagnostics player reported a 52.4 percent year-on-year rise in consolidated net profit at Rs 109.3 crore for the July-September quarter of the current financial year
from Moneycontrol Business News https://ift.tt/vMnUTNX
No comments:
Post a Comment